COGT – cogent biosciences, inc. (US:NASDAQ)
Stock Stats
News
Cogent Biosciences (COGT) had its "sell (d-)" rating reaffirmed by Weiss Ratings.
Cogent Biosciences (COGT): Billionaire Stan Druckenmiller Admires Upside Potential of This Stock [Yahoo! Finance]
Cogent Biosciences: Blockbuster Potential, Premium Valuation, Still A 'Buy' [Seeking Alpha]
Cogent Biosciences Announces Submission of New Drug Application for Bezuclastinib in Gastrointestinal Stromal Tumors (GIST) [Yahoo! Finance]
Cogent Biosciences Announces Submission of New Drug Application for Bezuclastinib in Gastrointestinal Stromal Tumors (GIST)
Form 4 Cogent Biosciences, Inc. For: Apr 01 Filed by: Ferrante Karen Jean
Form 144 Cogent Biosciences, Inc. Filed by: Fairmount Funds Management LLC
Form SCHEDULE 13D/A Cogent Biosciences, Inc. Filed by: Fairmount Funds Management LLC
Form 4 Cogent Biosciences, Inc. For: Mar 31 Filed by: Fairmount Funds Management LLC
Form SCHEDULE 13G/A Cogent Biosciences, Inc. Filed by: VANGUARD GROUP INC
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.